🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of PR...
Status
Completed
Location
Protalex Investigative Site
Start Date
2012-11
Trial ID
NCT01749787
Pre-clinical and clinical evaluations show that PRTX- 100 has biological ac...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2015-09
Trial ID
NCT02401061
Treatments Being Tested
Pre-clinical and clinical evaluations show that PRTX- 100 has biological ac...
Status
Terminated
Location
Haut-Levêque Hospital
Start Date
2015-11
Trial ID
NCT02566603
The primary purpose of this study is to evaluate the safety of multiple dos...
Status
Terminated
Location
Canberra Hospital
Start Date
2007-12
Trial ID
NCT00571467
Treatments Being Tested
Part A Primary Objective To determine the safety of six months of PRTX-100 ...
Status
Completed
Location
Protalex Investigational Site
Start Date
2015-02
Trial ID
NCT02330445
Treatments Being Tested
This study is the second human clinical study with PRTX-100. It is designed...
Status
Completed
Location
Buffalo Clinical Research Center
Start Date
2007-06
Trial ID
NCT00517855
Treatments Being Tested